Dr. Alan’s laboratory will be focused on the regulation of certain
signal transduction pathway as they relate to development and cancer using the worm C. elegans as well as human cells in culture.
Dr. Bell’s laboratory studies the regulation of breathing and the effect of opioids in preventing augmented breaths with potential treatments in animal models and human subjects.
Dr. Conway’s laboratory will study the mechanism(s) of viral entry into cells in the mosquito.
Robert Fleischmann and Daniel Griffin:
Drs. Fleischmann and Griffin’s laboratory is focused on molecular and cellular biological approaches to developing a cancer vaccine using cultured human cells and rodent models.
Dr. Hickman conducts epidemiologic research on cardiovascular therapies and their outcomes.
Dr. Johansen’s laboratory is interested in developing and studying reliable mouse models of neurodegenerative diseases such as Parkinson’s and Kennedy’s diseases.
Dr. McKee’s laboratory is involved with studying mitochondrial
function and biogenesis in rat models as it relates to human diseases.
Current work is focused on understanding the mechanism(s) of
mitochondrial toxicity of anti-viral drugs such as Zidovudine (AZT) and certain antibiotics such as Zyvox.
Dr. Miller-Monfils’ laboratory is focused on the causes, prevention, and treatment of hydrocephaly in rodent models.
Dr. Rengasamy’s laboratory studies the embryological mechanism(s) of birth defects associated with maternal diabetes in rodent models.
Dr. Rossignol’s laboratory is focused on developing stem cell technology therapies for neurodegenerative diseases such as Huntington’s and Alzheimer’s diseases in rodent models.
Dr. Vij’s laboratory will study the regulation of proteolysis in the lung as it relates to chronic obstructive pulmonary diseases (COPD), cystic fibrosis, and exposure to tobacco smoke using cell culture and rodent models.